CVS Health Co. (NYSE:CVS) Shares Sold by Alliance Wealth Advisors LLC

Alliance Wealth Advisors LLC decreased its position in CVS Health Co. (NYSE:CVS) by 82.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 4,462 shares of the pharmacy operator’s stock after selling 20,284 shares during the period. Alliance Wealth Advisors LLC’s holdings in CVS Health were worth $281,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. First Community Trust NA increased its holdings in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health in the third quarter valued at approximately $33,000. Steph & Co. raised its position in shares of CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares during the last quarter. ORG Partners LLC lifted its stake in CVS Health by 11,840.0% in the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 592 shares in the last quarter. Finally, Oliver Lagore Vanvalin Investment Group grew its holdings in CVS Health by 71.0% during the 2nd quarter. Oliver Lagore Vanvalin Investment Group now owns 595 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 247 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on CVS shares. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Wells Fargo & Company upped their target price on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a report on Monday, August 12th. Truist Financial lifted their price target on shares of CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a report on Friday, October 11th. Evercore ISI upped their price objective on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Finally, Barclays raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $63.00 to $82.00 in a research note on Thursday, October 10th. Nine analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $75.26.

CVS Health Trading Up 0.0 %

NYSE CVS opened at $65.01 on Thursday. The firm has a market capitalization of $81.61 billion, a price-to-earnings ratio of 11.43, a PEG ratio of 0.93 and a beta of 0.54. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company’s 50 day moving average price is $59.62 and its 200 day moving average price is $60.73.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The business had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. During the same quarter last year, the firm posted $2.21 EPS. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. On average, sell-side analysts predict that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.09%. CVS Health’s payout ratio is currently 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.